Metraipolis › archive › dc_56990ceeec3a
Mesothelin as Biomarker and Therapeutic Target for Immunotherapy in Cancer — Europe PMC PMID:42798783
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42798783
- DOI
- 10.1002/mco2.71009
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-07T21:18:31.406Z
- SHA-256 of the archived text
06832fe33d27124446cf7dc66e268957e835b9805acd7ba828a5b37b2d73febe- Stable URL of this page
https://metraipolis.com/documento/dc_56990ceeec3a
How to cite
Mesothelin as Biomarker and Therapeutic Target for Immunotherapy in Cancer — Europe PMC PMID:42798783 — Europe PMC (en), https://europepmc.org/article/MED/42798783 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_56990ceeec3a (Metraipolis archive dc_56990ceeec3a, sha256 06832fe33d27124446cf7dc66e268957e835b9805acd7ba828a5b37b2d73febe)
BibTeX
@misc{dc56990ceeec3a,
title = {Mesothelin as Biomarker and Therapeutic Target for Immunotherapy in Cancer — Europe PMC PMID:42798783},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42798783},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_56990ceeec3a; sha256 06832fe33d27124446cf7dc66e268957e835b9805acd7ba828a5b37b2d73febe},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42798783. Agents can read the archived copy with the MCP tool read_document.